We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

193 hedge funds and large institutions have $90.9M invested in Editas Medicine in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $596K

78% more capital invested

Capital invested by funds: $51M → $90.9M (+$39.9M)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

1% less funds holding

Funds holding: 194 → 193 (-1)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

3.69% less ownership

Funds ownership: 53.03% → 49.34% (-3.7%)

Holders
193
Holders Change
-1
Holders Change %
-0.52%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
52
Closed
26
Calls
$1.83M
Puts
$596K
Net Calls
+$1.24M
Net Calls Change
+$907K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.6M
2
WP
Woodline Partners
California
+$1.38M
3
N
Nuveen
North Carolina
+$1.04M
4
Citadel Advisors
Citadel Advisors
Florida
+$854K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$587K

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$3.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.03M
3
UBS Group
UBS Group
Switzerland
-$959K
4
Bank of America
Bank of America
North Carolina
-$717K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
176
Advisornet Financial
Minnesota
$110 -$164 -100 -67%
CFFP
177
Center for Financial Planning
Michigan
$110 – – –
NRG
178
Nemes Rush Group
Michigan
$110 – – –
KWM
179
Kiker Wealth Management
Georgia
$110 +$82 +50 New
MWM
180
MorganRosel Wealth Management
Colorado
$88 – – –
MAWAG
181
Mid-American Wealth Advisory Group
Missouri
$88 +$65 +40 New
NSIM
182
North Star Investment Management
Illinois
$84 – – –
CTA
183
Colonial Trust Advisors
South Carolina
$66 – – –
CA
184
Clearstead Advisors
Ohio
$55 – – –
WT
185
Whittier Trust
California
$55 – – –
MCM
186
MAI Capital Management
Ohio
$49 – – –
MYIA
187
Mount Yale Investment Advisors
Colorado
$44 +$33 +20 New
HI
188
Harbour Investments
Wisconsin
$42 – – –
Northwestern Mutual Wealth Management
189
Northwestern Mutual Wealth Management
Wisconsin
$15 +$10 +6 +600%
FP
190
Financial Perspectives
Minnesota
$13 – – –
AUB
191
Atlantic Union Bankshares
Virginia
$5 +$3 +2 New
MA
192
MCF Advisors
Kentucky
$3 – – –
UBS AM
193
UBS AM
Illinois
– -$3.02M -2,600,000 Closed
SEI Investments
194
SEI Investments
Pennsylvania
– -$96.5K -83,158 Closed
TI
195
Tidal Investments
Wisconsin
– -$87.8K -75,674 Closed
Thrivent Financial for Lutherans
196
Thrivent Financial for Lutherans
Minnesota
– -$71K -61,111 Closed
JG
197
Jain Global
New York
– -$48.9K -42,186 Closed
CF
198
Corebridge Financial
Texas
– -$47.1K -40,602 Closed
SG Americas Securities
199
SG Americas Securities
New York
– -$37K -31,516 Closed
TCM
200
Teza Capital Management
Illinois
– -$27.7K -23,872 Closed
5 6 7
8
9

EDIT Hedge Fund Activity: Q2 2025 in Review

193 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2025, worth a combined $90.9M — up 78% from $51M a quarter earlier.

Fund positioning in EDIT was balanced in Q2 2025: 26 funds opened new positions, 26 closed out, 48 added to existing stakes and 52 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.6M. The largest seller was UBS AM, exiting entirely with an estimated $3.02M sold.

  • 193 institutional investors held Editas Medicine (EDIT) as of Q2 2025, down from 194 in Q1 2025.
  • Funds reported $90.9M of Editas Medicine stock for Q2 2025, up 78% quarter-over-quarter.
  • 26 funds opened new Editas Medicine positions in Q2 2025 and 26 closed out, a net change of 0 holders.
  • The largest Editas Medicine buyer in Q2 2025 was Millennium Management, an estimated $2.6M added.
  • The largest Editas Medicine seller in Q2 2025 was UBS AM, an estimated $3.02M sold.

Based on aggregated 13F filings for Q2 2025.